BriaCell Therapeutics (TSE:BCT) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BriaCell Therapeutics has successfully closed a $5.5 million public offering, selling 7.4 million common shares and accompanying warrants. The company plans to allocate the proceeds toward working capital, corporate purposes, and advancing its business goals. ThinkEquity served as the sole book-running manager for this offering.
For further insights into TSE:BCT stock, check out TipRanks’ Stock Analysis page.